Особенности современного образа жизни привели к тому, что в экономически развитых странах 30% населения имеют избыточную массу тела [1]. За последние 15-20 лет произошло кардинальное изменение представлений о физиологической роли жировой ткани. Если раньше ее рассматривали в качестве исключительно энергетического депо, аккумулирующего жирные кислоты, то в настоящее время жировую ткань представляют как эндокринный орган [2]. Результаты исследований [3] показали, что жировая ткань продуцирует широкий спектр адипокинов, которые оказывают влияние на метаболические процессы, иммунный статус, состояние сосудистого эндотелия и многие другие показатели
Target: to give the clinical and immunologic evaluation of the combined chlamydial and herpetic infection of the urogenital tract and to study the possibility of the immunomodulating therapy at this category of patients. Маterial and methods The open short term prospective randomized clinical and immunologic study comprises 93 women of reproductive age, suffering from chlamydial and herpetic infection of the low section of the reproductive tract. Besides the basic therapy (acyclovir 200 mg 5 times a day No7, azithromycin 1,0 No 1) the index group (n=52) received such immunomodulator as tiloron, the basic therapy group (n=4) received only basic therapy. The experimental group (n=50) comprised apparently healthy women, selected during prophylactic examinations. Results. After the monthly treatment in the experimental group Chlamydia was revealed at 12,1%, HSV at 9,7% of women. In the index group it was 1,9 and 3,8% accordingly. At the repeated control after a month in the index group Chlamydia was not revealed at у 98%, HSV - at 96,1%. It was 87,8 and 80,5% in the experimental group accordingly (р
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.